(2026). HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study. Journal of Hepatocellular Carcinoma.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study."
Journal of Hepatocellular Carcinoma 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study."
Journal of Hepatocellular Carcinoma, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.